Showing results (71-80 of 3,147) with videos related to
Sort By:
Pageof 315
Neuro-Oncology|March 13, 2012
Impaired survival and long-term neurological problems in benign meningiomaHanna van Alkemade, Michelle de Leau, Edith M T Dieleman, et al.Neuro-Oncology|September 23, 2008
Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphomaMichael Linnebank, Susanna Moskau, Annika Jürgens, et al.Neuro-Oncology|September 6, 2008
Bevacizumab and carboplatin increase survival and asymptomatic tumor volume in a glioma modelKristoph Jahnke, Leslie L Muldoon, Csanad G Varallyay, et al.Neuro-Oncology|September 10, 2008
Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131Michael A Vogelbaum, Brian Berkey, David Peereboom, et al.Neuro-Oncology|September 11, 2008
Sagopilone crosses the blood-brain barrier in vivo to inhibit brain tumor growth and metastasesJens Hoffmann, Iduna Fichtner, Margit Lemm, et al.Neuro-Oncology|July 31, 2008
Global analysis of the medulloblastoma epigenome identifies disease-subgroup-specific inactivation of COL1A2Jennifer A Anderton, Janet C Lindsey, Meryl E Lusher, et al.Neuro-Oncology|February 16, 2022
Preoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomasGaia Ninatti, Martina Sollini, Beatrice Bono, et al.Neuro-Oncology|February 9, 2022
The impact of brain invasion criteria on the incidence and distribution of WHO grade 1, 2, and 3 meningiomasAlexander D Rebchuk, Bradley M Chaharyn, Armaghan Alam, et al.Neuro-Oncology|February 14, 2022
Distinct metabolic hallmarks of WHO classified adult glioma subtypesBenny Björkblom, Carl Wibom, Maria Eriksson, et al.Neuro-Oncology|February 14, 2022
Quantifying the risk and dosimetric variables of symptomatic brainstem injury after proton beam radiation in pediatric brain tumorsRituraj Upadhyay, Kaiping Liao, David R Grosshans, et al.Pageof 315